BSX240816P80000
- 3.40
- +0.47+16.04%
Boston Scientific Newsroom
Raymond James Maintains Boston Scientific(BSX.US) With Buy Rating, Raises Target Price to $91
Morgan Stanley Maintains Boston Scientific(BSX.US) With Buy Rating, Maintains Target Price $92
A Quick Look at Today's Ratings for Boston Scientific(BSX.US), With a Forecast Between $85 to $91
Boston Scientific Price Target Raised to $91.00/Share From $90.00 by Baird
Buy Rating Reiterated for Boston Scientific on Strong Quarterly Performance and Uplifted Outlook
Citi Sticks to Its Buy Rating for Boston Scientific (BSX)
Boston Scientific Analyst Ratings
Redburn Atlantic Adjusts Price Target on Boston Scientific to $85 From $79, Maintains Buy Rating
Buy Rating Affirmed: Boston Scientific's Strong Performance and Upward Financial Projections
Evercore ISI Adjusts Price Target on Boston Scientific to $82 From $81
Jefferies Remains a Buy on Boston Scientific (BSX)
Jefferies Maintains Boston Scientific(BSX.US) With Buy Rating, Maintains Target Price $82
TD Cowen Adjusts Price Target on Boston Scientific to $86 From $77
Critical Insights From Boston Scientific Analyst Ratings: What You Need To Know
BTIG Adjusts Price Target on Boston Scientific to $84 From $80, Maintains Buy Rating
Mizuho Adjusts Price Target on Boston Scientific to $100 From $90
Boston Scientific Analyst Ratings
Citigroup Adjusts Price Target on Boston Scientific to $90 From $87
Boston Scientific Analyst Ratings
Evercore ISI Adjusts Price Target on Boston Scientific to $81 From $78, Maintains Outperform Rating